The European Medicines Agency has finalized its reflection paper on a tailored clinical approach to biosimilar development, ...
The paper highlights the potential of AI in the medicinal product lifecycle and the approach that developers should take with it. The European Medicines Agency (EMA) published a draft reflecting paper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results